These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27639457)

  • 1. Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Neurosci Res; 2017 Jan; 114():9-15. PubMed ID: 27639457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat.
    Milani D; Cross JL; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    Brain Res Bull; 2017 Oct; 135():62-68. PubMed ID: 28964774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuroprotective efficacy of poly-arginine R18 and R18D (D-enantiomer) peptides following permanent middle cerebral artery occlusion in the Wistar rat and in vitro toxicity studies.
    Milani D; Bakeberg MC; Cross JL; Clark VW; Anderton RS; Blacker DJ; Knuckey NW; Meloni BP
    PLoS One; 2018; 13(3):e0193884. PubMed ID: 29513757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat.
    Milani D; Knuckey NW; Anderton RS; Cross JL; Meloni BP
    Stroke Res Treat; 2016; 2016():2372710. PubMed ID: 27247825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model.
    Milani D; Clark VW; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    BMC Neurosci; 2016 May; 17(1):19. PubMed ID: 27142074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Neuroprotective Effects of Arginine-Rich Protamine Peptides, Poly-Arginine Peptides (R12-Cyclic, R22) and Arginine-Tryptophan-Containing Peptides Following In Vitro Excitotoxicity and/or Permanent Middle Cerebral Artery Occlusion in Rats.
    Meloni BP; Milani D; Cross JL; Clark VW; Edwards AB; Anderton RS; Blacker DJ; Knuckey NW
    Neuromolecular Med; 2017 Sep; 19(2-3):271-285. PubMed ID: 28523591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Assessment of the Proteolytic Stability and Impact of Poly-Arginine Peptides R18 and R18D on Infarct Growth and Penumbral Tissue Preservation Following Middle Cerebral Artery Occlusion in the Sprague Dawley Rat.
    Milani D; Clark VW; Feindel KW; Blacker DJ; Bynevelt M; Edwards AB; Anderton RS; Knuckey NW; Meloni BP
    Neurochem Res; 2021 May; 46(5):1166-1176. PubMed ID: 33523394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroprotective effect of lercanidipine in middle cerebral artery occlusion model of stroke in rats.
    Gupta S; Sharma U; Jagannathan NR; Gupta YK
    Exp Neurol; 2017 Feb; 288():25-37. PubMed ID: 27794423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly-Arginine Peptides R18 and R18D Improve Functional Outcomes After Endothelin-1-Induced Stroke in the Sprague Dawley Rat.
    Meloni BP; South SM; Gill DA; Marriott AL; Déziel RA; Jacques A; Blacker DJ; Knuckey NW
    J Neuropathol Exp Neurol; 2019 May; 78(5):426-435. PubMed ID: 30888409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat.
    Edwards AB; Cross JL; Anderton RS; Knuckey NW; Meloni BP
    Mol Brain; 2018 Feb; 11(1):8. PubMed ID: 29426351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly-Arginine Peptide-18 (R18) Reduces Brain Injury and Improves Functional Outcomes in a Nonhuman Primate Stroke Model.
    Meloni BP; Chen Y; Harrison KA; Nashed JY; Blacker DJ; South SM; Anderton RS; Mastaglia FL; Winterborn A; Knuckey NW; Cook DJ
    Neurotherapeutics; 2020 Apr; 17(2):627-634. PubMed ID: 31833045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSD-95 inhibitor Tat-NR2B9c (NA-1) protects the integrity of the blood-brain barrier after transient middle artery occlusion in rats by downregulating matrix metalloprotease-9 and upregulating endothelial nitric oxide synthase.
    Xu Y; Xu L; Xu C; Zhao M; Xu T; Xia L; Wu Y; Cao Y; Han Z
    Brain Res Bull; 2024 Jan; 206():110836. PubMed ID: 38042504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection of taurine through inhibition of 12/15 lipoxygenase pathway in cerebral ischemia of rats.
    Zhang Z; Yu R; Cao L
    Neurol Res; 2017 May; 39(5):453-458. PubMed ID: 28256152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside rd in experimental stroke: superior neuroprotective efficacy with a wide therapeutic window.
    Ye R; Kong X; Yang Q; Zhang Y; Han J; Li P; Xiong L; Zhao G
    Neurotherapeutics; 2011 Jul; 8(3):515-25. PubMed ID: 21647765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotective effect of SolCD39, a novel platelet aggregation inhibitor, on transient middle cerebral artery occlusion in rats.
    Belayev L; Khoutorova L; Deisher TA; Belayev A; Busto R; Zhang Y; Zhao W; Ginsberg MD
    Stroke; 2003 Mar; 34(3):758-63. PubMed ID: 12624304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyruvate's blood glutamate scavenging activity contributes to the spectrum of its neuroprotective mechanisms in a rat model of stroke.
    Boyko M; Zlotnik A; Gruenbaum BF; Gruenbaum SE; Ohayon S; Kuts R; Melamed I; Regev A; Shapira Y; Teichberg VI
    Eur J Neurosci; 2011 Nov; 34(9):1432-41. PubMed ID: 21936878
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intraventricular infusion of vascular endothelial growth factor on cerebral blood flow, edema, and infarct volume.
    Harrigan MR; Ennis SR; Sullivan SE; Keep RF
    Acta Neurochir (Wien); 2003 Jan; 145(1):49-53. PubMed ID: 12545262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-ischemic vascular adhesion protein-1 inhibition provides neuroprotection in a rat temporary middle cerebral artery occlusion model.
    Watcharotayangul J; Mao L; Xu H; Vetri F; Baughman VL; Paisansathan C; Pelligrino DA
    J Neurochem; 2012 Nov; 123 Suppl 2(Suppl 2):116-24. PubMed ID: 23050649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of PSD95 inhibitors in permanent and transient focal ischemia in the rat.
    Sun HS; Doucette TA; Liu Y; Fang Y; Teves L; Aarts M; Ryan CL; Bernard PB; Lau A; Forder JP; Salter MW; Wang YT; Tasker RA; Tymianski M
    Stroke; 2008 Sep; 39(9):2544-53. PubMed ID: 18617669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroprotective effects of erythromycin on ischemic injury following permanent focal cerebral ischemia in rats.
    Katayama Y; Inaba T; Nito C; Ueda M
    Neurol Res; 2016 Mar; 38(3):275-84. PubMed ID: 27078702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.